-
-
-
-
-
-
-
Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
-
-
-
-
-
-
-
Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 191c
-
-
-
-
-
-
-
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
-
-
-
-
-
-
-
Aligos appoints Ramón Polo as head of global regulatory affairs
-
-
-
-
-
-
-
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
-
-
-
-
-
-
-
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
-
-
-
-
-
-
-
Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
-
1,224,066 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

